#healthtech Tag

The planning assumptions that worked in 2022 are quietly failing. In 2022, healthcare CIOs were building business cases for AI pilots. In 2026, they're being asked why the pilots haven't become products. In 2022, cybersecurity was a compliance topic. In 2026, the Change Healthcare ransomware attack — which affected 192.7 million Americans, roughly two-thirds of the US population — turned it into a board-level operational risk that no CTO can defer. In 2022, interoperability was a regulatory aspiration. In 2026, it's a technical prerequisite for any system that touches patient data.

Clinical companies entering the second half of the decade are navigating a different kind of pressure. Budgets are tighter: 41% of health system executives anticipate reduced capital investment over the next two years, according to a March 2026 survey by Sage Growth Partners. The window for exploratory technology spending is narrowing. At the same time, the expectations for what technology needs to deliver — in clinical efficiency, data security, and measurable patient outcomes — have grown sharply. Every line item now needs a business case, and every business case needs to hold up against harder questions than it would have two or three years ago.

Healthcare Technology Priorities

Healthcare has a data problem — not a shortage of it, but an inability to act on it. The average large health system generates hundreds of millions of clinical events annually. Claims databases hold years of longitudinal patient history. EHRs log every medication, every vital sign, every lab result. And most of that data sits in silos, incompatible formats, and legacy systems that were never designed to talk to each other. Organizations that turn clinical, pharmaceutical and financial data into better decisions use purpose-built healthcare analytics platforms. In 2026, these platforms must support FHIR interoperability, near real-time population health analytics, value-based care, and AI-driven insights. But not all healthcare analytics solutions are the same. The market ranges from FHIR-native clinical intelligence platforms to general-purpose BI tools with healthcare connectors. Choosing the wrong solution can lead to costly implementations, limited clinical capabilities, and analytics that can't scale with your healthcare data. This guide profiles seven leading healthcare analytics solutions for 2026, evaluated on clinical depth, interoperability support, analytical sophistication, and fit for healthcare-specific workflows. They are not all the same — and that distinction matters.

The phrase "custom AI solutions for healthcare" has been stretched to cover everything from a chatbot that answers FAQ questions to a clinician-reviewed diagnostic model trained on 10 million labeled images. That spectrum matters for vendor selection, because the right company for a conversational patient engagement tool is categorically different from the right company for a radiology AI system. This guide focuses on companies building meaningful custom AI — systems that process clinical data, generate outputs that influence care or operations, and operate under regulatory frameworks that hold their developers accountable for what those outputs say. Seven companies are profiled, each evaluated with a Strengths / Limitations / Verdict framework that gives you a direct, unhedged read on what each company does well and where it falls short.

[caption id="attachment_74022" align="aligncenter" width="500"]women's-health-trackers.jpg Photo by Ketut Subiyanto[/caption] Women's health technology has come a long way from basic period tracking apps. Today, a new generation of devices and platforms is giving women access to the kind of hormone data that used to require a doctor's appointment, a lab order, and a two-week wait for results. From continuous glucose monitors to AI-powered saliva analyzers, the tools of 2026 are helping women understand what's actually happening inside their bodies - in real time, at home, on their own terms. Whether you're trying to conceive, managing PCOS, navigating perimenopause, or simply wanting a clearer picture of your metabolic health, there's now a tracker built for your specific journey. We've rounded up three of the most compelling options on the market this year.

  In recent years, the health tech industry has seen a surge in groundbreaking innovations, from wearable medical devices to AI-powered diagnostics. While these advancements can potentially transform healthcare, they often come with a barrier‚Äîcomplexity. Many of these technologies are sophisticated, requiring expert knowledge to understand fully. Public relations (PR) in health is critical in translating these innovations into accessible information for the general public. By making these advancements relatable and transparent, PR efforts build trust and enable wider adoption of life-improving technologies. [caption id="attachment_64718" align="aligncenter" width="500"] Photo by Max Mishin[/caption]

Challenges in Communicating Healthtech Innovations

Communicating health tech innovations effectively has its challenges. Healthtech is a field rooted in medical science and advanced technology, leading to complex terminology that can be hard for the average person to follow. For instance, AI applications in diagnostics or personalized medicine might sound overwhelming and abstract, making it difficult for the public to appreciate their value or even feel comfortable using them.   Beyond complexity, there are ethical and privacy concerns. Data privacy, particularly in health, is a sensitive area, and the public often has questions or worries about how their data will be managed. Additionally, the fear of misuse or misinterpretation of health data can increase without clear communication. In this challenging landscape, PR is responsible for addressing both the technical aspects and the ethical questions in ways the public can understand and trust.